Market Place
Sourcing Support
PharmaJet Partner, Scancell, Announces Positive Data from Phase 2 Trial
28 Sep 2023 //
BUSINESSWIRE
Scancell enjoys stock bounce on back of cancer vaccine data
19 Sep 2023 //
FIERCE BIOTECH
Scancell shares encouraging results from phase 1/2 cancer trial
21 Feb 2023 //
PHARMAFILE
Giving first glimpse of data, Scancell looks for Covid-19 vaccine partner
13 Feb 2023 //
ENDPTS
Scancell`s PII Melanoma DNA Vaccine Trial will include Needle-free Delivery
02 Aug 2022 //
BUSINESSWIRE
First patient dosed in Scancell’s clinical trial for multiple cancers
13 Jun 2022 //
PHARMATIMES
Scancell Holdings doses first patient with second Covid vaccine candidate
31 Jan 2022 //
PROACTIVEINVESTORS
PharmaJet selected to deliver Scancell COVID-19 DNA Vaccines
14 Sep 2021 //
BUSINESSWIRE
Update on SCIB2 clinical development partnership
03 Feb 2021 //
PRESS
Scancell Consortium Gets Innovate UK Funding For Covid Vaccine Trial
27 Aug 2020 //
LSE
Scancell receives funding for COVID-19 vaccine development
26 Aug 2020 //
PHARMATIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.